Researchers dont know why some people whose stories were featured in the new case series experienced better results.
And experts cautioned that we cant say for certain that Paxlovid drove the improvement.
Some participants didnt see any improvement, others saw temporary improvement, and some saw lasting improvement.
Delmaine Donson
The study is limited in that the authors dont know what caused the improvement some patients experienced.
One theory is that Paxlovid may kill lingering remnants of the virus in some people, said Dr. Schaffner.
Some participants saw no improvement, others saw temporary improvement, and others saw lasting improvement.
But experts dont know why the drug may have helped some people and not others.
2024;184(9):1024. doi:10.1001/jamainternmed.2024.2007
Centers for Disease Control and Prevention.Long COVID Basics.
